RMR Q1 2026 Earnings EPS Misses Estimates by 222 Amid Elevated Operating Costs XORTX Therapeutics Q1 2024 Earnings Steep EPS Miss Highlights PreRevenue Biotech Hurdles MTH Q1 2026 Earnings EPS Misses Estimates Stock Inches Higher EFC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response XLO Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares ACU Q1 2026 Earnings Missed Earnings Estimates but Stock Gains on Operational Resilience